Kardiologia polska最新文献_第3页

Ultra-long term histopathological workup of an Amplatzer Muscular Septal Defect Occluders after surgical removal of the heart due to heart transplantation. 心脏移植手术切除心脏后，对 Amplatzer 肌肉性房间隔缺损封堵器进行超长期组织病理学检查。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102782

Jacek Białkowski, Roland Fiszer, Tomasz Hrapkowicz, Szymon Pawlak, Alina Zdrzałek-Skiba, Jerzy Nożyński, Rafał Skowronek, Małgorzata Szkutnik

引用次数: 0

In-stent restenosis risk factors following carotid artery stenting. 颈动脉支架术后支架内再狭窄的风险因素。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102555

Mesut Engin, Abdurrahman Demirel, Ufuk Aydın, Yusuf Ata, Şenol Yavuz

引用次数: 0

Effectiveness of first-pass pulmonary vein isolation with ablation index-guided ablation compared with very-high-power, short-duration ablation: A retrospective, single-center study. 消融指数引导下的首次肺静脉隔离术与超高功率、短时间消融术的效果比较：一项回顾性单中心研究。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102553

Michał Peller, Julia Dźwinacka, Bartosz Krzowski, Michał Marchel, Cezary Maciejewski, Karolina Mitrzak, Grzegorz Opolski, Marcin Grabowski, Paweł Balsam, Piotr Lodziński

引用次数: 0

Reevaluate the effect of ACEI/ARB therapy at discharge on patients with STEMI in the contemporary reperfusion era. 在当代再灌注时代，重新评估 STEMI 患者出院时接受 ACEI/ARB 治疗的效果。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102772

Mengjin Hu, Chuangshi Wang, Jingang Yang, Xiaojin Gao, Yuejin Yang

{"title":"Reevaluate the effect of ACEI/ARB therapy at discharge on patients with STEMI in the contemporary reperfusion era.","authors":"Mengjin Hu, Chuangshi Wang, Jingang Yang, Xiaojin Gao, Yuejin Yang","doi":"10.33963/v.phj.102772","DOIUrl":"https://doi.org/10.33963/v.phj.102772","url":null,"abstract":"Background: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) had beneficial effects on clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) in the pre-reperfusion or thrombolytic era. It is unknown if the benefits persist in the contemporary reperfusion era.Objectives: We sought to determine if ACEI/ARB improves clinical outcomes of patients with STEMI in the contemporary reperfusion era according to the reperfusion strategy.Methods: 12596 patients were analyzed from the prospective, nationwide, multicenter China Acute Myocardial Infarction (CAMI) Registry. These patients were classified into the no reperfusion group (n=6004) and the primary percutaneous coronary intervention (PCI) group (n=6592). Two-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE) were compared.Results: In the no reperfusion group, ACEI/ARB therapy at discharge may reduce the incidences of 30-day MACCE (4.7% vs 7.4%; adjusted hazard ratio [HR]: 0.67; 95% confidence interval [CI]: 0.53-0.85; P<0.001), stroke (0.5% vs 1.1%; adjusted HR: 0.41; 95% CI: 0.21-0.83; P=0.01), and revascularization (2.1% vs 3.1%; adjusted HR: 0.66; 95% CI: 0.46-0.94; P=0.02) compared to patients not treated with ACEI/ARB. Patients treated with ACEI/ARB also showed a lower rate of two-year MACCE (17.0% versus 19.1%; adjusted HR: 0.87; 95% CI: 0.76-0.99; P=0.04). No differences were observed in the remaining outcomes. In the primary PCI group, no differences were observed for all examined outcomes before and after multivariate adjustments.Conclusions: Treatment with ACEI/ARB at discharge may reduce cardiovascular events in STEMI patients not receiving reperfusion, while no significant benefits were observed in those receiving primary PCI.","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prognostic value of the monocyte-to-high-density lipoprotein-cholesterol ratio in ACS patients: A systematic review and meta-analysis. ACS 患者单核细胞与高密度脂蛋白胆固醇比值的预后价值：系统回顾和荟萃分析。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102773

Michał Pruc, Jacek Kubica, Maciej Banach, Damian Świeczkowski, Zubaid Rafique, William Frank Peacock, Zbigniew Siudak, Stanisław Surma, Prabath Nanayakkara, Krzysztof Kurek, Anne Lepetit, Łukasz Szarpak

{"title":"Prognostic value of the monocyte-to-high-density lipoprotein-cholesterol ratio in ACS patients: A systematic review and meta-analysis.","authors":"Michał Pruc, Jacek Kubica, Maciej Banach, Damian Świeczkowski, Zubaid Rafique, William Frank Peacock, Zbigniew Siudak, Stanisław Surma, Prabath Nanayakkara, Krzysztof Kurek, Anne Lepetit, Łukasz Szarpak","doi":"10.33963/v.phj.102773","DOIUrl":"https://doi.org/10.33963/v.phj.102773","url":null,"abstract":"Background: Globally, diseases of the cardiovascular system stand as the principal contributors to mortality and are anticipated to show an upward trajectory. The occurrence of Acute Coronary Syndrome (ACS) has been linked to underlying inflammatory processes. The monocyte-to-high-density lipoprotein-cholesterol (MHR) ratio has garnered significant attention as a prognostic biomarker, encapsulating the synergistic roles of inflammation and lipid metabolism in the pathophysiology of cardiovascular diseases, including ACS.Aims: This meta-analysis examines the prognostic MHR ratio in ACS patients.Methods: We systematically searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library databases to identify the relevant meta-analyses up to February 26, 2024. The findings were aggregated into risk ratios with 95% confidence intervals.Results: Eleven studies, with 7421 patients, were included. Low MHR levels compared to high MHR levels were associated with statistically significantly lower in-hospital mortality (0.9% vs. 5.5%; respectively; p<0.001), 3-month mortality (4.4% vs. 11.2%; p = 0.02), 6-month follow-up mortality (4.0% vs. 10.2%; p = 0.03), 1-year mortality (4.2%, vs. 10.2%; p<0.001), as well as long-term follow-up mortality (7.5% vs. 13.7%; p<0.001).Conclusions: MHR has both good predictive properties for mortality and MACE (short- and long-term). Data indicate that MHR may improve in-hospital and long-term cardiovascular risk prediction. It may, therefore, be an effective tool for risk re-estimation and the selection of patients for whom intensive lipid-lowering treatment may be particularly useful.","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluating the effect of coronary atherosclerosis on the occurrence of atrial fibrillation through coronary computed tomography angiography. 通过冠状动脉计算机断层扫描血管造影评估冠状动脉粥样硬化对心房颤动发生的影响。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102554

Andrzej Hasiec, Mariusz Kruk, Cezary Kępka, Grzegorz Warmiński, Ilona Kowalik, Maria Bilińska, Łukasz Szumowski

{"title":"Evaluating the effect of coronary atherosclerosis on the occurrence of atrial fibrillation through coronary computed tomography angiography.","authors":"Andrzej Hasiec, Mariusz Kruk, Cezary Kępka, Grzegorz Warmiński, Ilona Kowalik, Maria Bilińska, Łukasz Szumowski","doi":"10.33963/v.phj.102554","DOIUrl":"https://doi.org/10.33963/v.phj.102554","url":null,"abstract":"Background: The direct impact of atherosclerotic lesions in coronary vessels on the occurrence of atrial fibrillation (AF) in patients without a history of acute myocardial ischemia, previous myocardial infarction, or revascularization procedures remains largely unknown.Aims: To assess the risk and predictors of new-onset AF in patients with coronary atherosclerosis confirmed by coronary computed tomography angiography (CCTA).Methods: We included consecutive patients referred for CCTA who had been observed and diagnosed with new-onset AF over 10 years.Results: Of the 549 patients enrolled in the study, 208 (37.9%) were diagnosed with atherosclerotic lesions in the coronary vessels and 63 (11.5%) developed AF during the 10 years of observation. Patients with AF were older (61.8 [10.4] years vs. 58.3 [9.2] years; P = 0.005), had an enlarged left atrium in the anteroposterior dimension (38.2 [7.2] mm vs. 34.4 [5.4] mm; P < 0.001), and had a widened interventricular septum (12.3 [2.0] mm vs. 11.0 [2.1] mm; P < 0.001). We also found a significant correlation between the occurrence of AF in patients with coronary atherosclerotic lesions and with increased thickness of the interventricular septum relative to the posterior wall of the left ventricle (P = 0.017).Conclusions: Our data indicate an association between coronary atherosclerosis and the greater risk of AF in patients with increased thickness of the interventricular septum relative to the posterior wall of the left ventricle. This finding suggests that by using CCTA we can predict which patients are at higher risk of developing AF.","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Late gadolinium enhancement in aortic stenosis: Is it an indication to surgical treatment in asymptomatic patients? 主动脉瓣狭窄的晚期钆增强：它是无症状患者手术治疗的指征吗？

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102581

Ewa Orłowska-Baranowska, Małgorzata Nieznańska, Magdalena Marczak, Mateusz Śpiewak, Łukasz Mazurkiewicz, Barbara Miłosz, Karina Zatorska, Ilona Kowalik, Rafał Baranowski, Tomasz Hryniewiecki

引用次数: 0

Computed tomography calcium scoring in routine clinical daily practice for assessing aortic valve stenosis severity. 计算机断层扫描钙化评分在日常临床实践中用于评估主动脉瓣狭窄的严重程度。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102780

Łukasz Wiewiórka, Jacek Legutko, Jarosław Trębacz, Paweł Kleczyński, Joanna Szachowicz-Jaworska, Maciej Krupiński, Paweł Banyś, Krzysztof Żmudka, Maciej Stąpór

引用次数: 0

T-cell acute lymphoblastic leukemia with involvement of extramedullary sites, including pericardium. 髓外部位（包括心包）受累的 T 细胞急性淋巴细胞白血病。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102552

Katarzyna Pomykała, Joanna Drozd-Sokołowska, Joanna Mączewska, Piotr Kacprzyk, Łukasz Bolkun, Grzegorz Styczyński, Agnieszka Tomaszewska, Grzegorz Basak

引用次数: 0

Transcatheter aortic valve implantation with Navitor Titan device: First Polish experience. 使用 Navitor Titan 设备进行经导管主动脉瓣植入术：波兰首次经验。

IF 3.7 3区医学

Kardiologia polska Pub Date : 2024-10-08 DOI: 10.33963/v.phj.102781

Jarosław Trębacz, Robert Sobczyński, Janusz Konstanty-Kalandyk, Maciej Stąpór, Michał Okarski, Bogusław Kapelak, Paweł Kleczyński, Jacek Legutko

引用次数: 0